MedTrace Logo

M1no-Study - Early Identification of Infants With High Type 1 Diabetes Risk for Participation in Primary Prevention Trials

NCT07670143 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2026-06-26

No results posted yet for this study

Summary

The goal of this observational study is to identify newborns at increased genetic risk of developing type 1 diabetes-specific beta-cell autoantibodies in order to determine eligibility for participation in primary prevention randomized controlled trials aimed at preventing beta-cell autoimmunity.

Conditions

Sponsors & Collaborators

  • Clinica Mangiagalli

    collaborator UNKNOWN

  • Azienda Ospedaliero Universitaria Maggiore della Carita

    collaborator OTHER

  • Azienda Socio Sanitaria Territoriale di Lecco

    collaborator OTHER

  • Ospedale F. Del Ponte, Varese

    collaborator UNKNOWN

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
0 Weeks
Max Age
6 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2031-06-30
Completion
2031-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07670143 on ClinicalTrials.gov